When researchers examined the animals
over the next
several months, they found that this approach
cured a much higher proportion of mice than delivery of the drug by other techniques.
The all - day meeting showcased the work of more than 100 experts from academia, federal and regulatory agencies, government research agencies, pharmaceutical and biotech industry, and patient advocacy community who have worked together
over the past
several months to prepare draft consensus recommendations on how to address the regulatory issues around HIV
cure research.